160 related articles for article (PubMed ID: 23143406)
1. Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile.
Al-Herz W; Alsmadi O; Melhem M; Recher M; Frugoni F; Notarangelo LD
J Clin Immunol; 2013 Apr; 33(3):513-9. PubMed ID: 23143406
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients.
Ouederni M; Vincent QB; Frange P; Touzot F; Scerra S; Bejaoui M; Bousfiha A; Levy Y; Lisowska-Grospierre B; Canioni D; Bruneau J; Debré M; Blanche S; Abel L; Casanova JL; Fischer A; Picard C
Blood; 2011 Nov; 118(19):5108-18. PubMed ID: 21908431
[TBL] [Abstract][Full Text] [Related]
3. The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population.
Naamane H; El Maataoui O; Ailal F; Barakat A; Bennani S; Najib J; Hassar M; Saile R; Bousfiha AA
Eur J Pediatr; 2010 Sep; 169(9):1069-74. PubMed ID: 20414676
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
Mousavi Khorshidi MS; Seeleuthner Y; Chavoshzadeh Z; Behfar M; Hamidieh AA; Alimadadi H; Sherkat R; Momen T; Behniafard N; Eskandarzadeh S; Mansouri M; Behnam M; Mahdavi M; Heydarazad Zadeh M; Shokri M; Alizadeh F; Movahedi M; Momenilandi M; Keramatipour M; Casanova JL; Cobat A; Abel L; Shahrooei M; Parvaneh N
J Clin Immunol; 2023 Nov; 43(8):1941-1952. PubMed ID: 37584719
[TBL] [Abstract][Full Text] [Related]
5. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
[TBL] [Abstract][Full Text] [Related]
6. Clinical, immunologic and genetic profiles of DOCK8-deficient patients in Kuwait.
Al-Herz W; Ragupathy R; Massaad MJ; Al-Attiyah R; Nanda A; Engelhardt KR; Grimbacher B; Notarangelo L; Chatila T; Geha RS
Clin Immunol; 2012 Jun; 143(3):266-72. PubMed ID: 22534316
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.
Klein C; Lisowska-Grospierre B; LeDeist F; Fischer A; Griscelli C
J Pediatr; 1993 Dec; 123(6):921-8. PubMed ID: 8229525
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report.
Abolnezhadian F; Dehghani R; Dehnavi S; Khodadadi A; Shohan M
Immunol Res; 2020 Aug; 68(4):225-231. PubMed ID: 32578129
[TBL] [Abstract][Full Text] [Related]
9. The Kuwait National Primary Immunodeficiency Registry 2004-2018.
Al-Herz W; Al-Ahmad M; Al-Khabaz A; Husain A; Sadek A; Othman Y
Front Immunol; 2019; 10():1754. PubMed ID: 31396239
[No Abstract] [Full Text] [Related]
10. Cellular and gene therapy for major histocompatibility complex class II deficiency.
Matheux F; Villard J
News Physiol Sci; 2004 Jun; 19():154-8. PubMed ID: 15143213
[TBL] [Abstract][Full Text] [Related]
11. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004--2006).
Al-Herz W
J Clin Immunol; 2008 Mar; 28(2):186-93. PubMed ID: 18008151
[TBL] [Abstract][Full Text] [Related]
12. Major Histocompatibility Complex Class II Deficiency due to a Novel Mutation in RFXANK in a Child of Mexican Descent.
Clarridge K; Leitenberg D; Loechelt B; Picard C; Keller M
J Clin Immunol; 2016 Jan; 36(1):4-5. PubMed ID: 26634365
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of hematopoietic stem cell transplantation in major histocompatibility complex class II deficiency.
Castano-Jaramillo LM; Bareño-Silva J; Tobon S; Escobar-Gonzalez AF
Pediatr Transplant; 2020 Sep; 24(6):e13774. PubMed ID: 32678504
[TBL] [Abstract][Full Text] [Related]
14. Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.
Ben-Mustapha I; Ben-Farhat K; Guirat-Dhouib N; Dhemaied E; Larguèche B; Ben-Ali M; Chemli J; Bouguila J; Ben-Mansour L; Mellouli F; Khemiri M; Béjaoui M; Barbouche MR
J Clin Immunol; 2013 May; 33(4):865-70. PubMed ID: 23314770
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Immunological, and Molecular Findings in Five Patients with Major Histocompatibility Complex Class II Deficiency from India.
Aluri J; Gupta M; Dalvi A; Mhatre S; Kulkarni M; Hule G; Desai M; Shah N; Taur P; Vedam R; Madkaikar M
Front Immunol; 2018; 9():188. PubMed ID: 29527204
[TBL] [Abstract][Full Text] [Related]
16. [A case of bronchiolitis due to pneumocystis lung infection related to major histocompatibility class II deficiency].
Hadchouel A; Madhi F; Delacourt C
Rev Mal Respir; 2006 Nov; 23(5 Pt 1):467-70. PubMed ID: 17314748
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class II deficiency needs an early diagnosis: report of a case.
Canioni D; Patey N; Cuenod B; Benkerrou M; Brousse N
Pediatr Pathol Lab Med; 1997; 17(4):645-51. PubMed ID: 9211559
[TBL] [Abstract][Full Text] [Related]
18. MHC class II-deficient combined immunodeficiency: a disease of gene regulation.
Mach B; Steimle V; Reith W
Immunol Rev; 1994 Apr; 138():207-21. PubMed ID: 8070816
[No Abstract] [Full Text] [Related]
19. MHC class II deficiency: Report of a novel mutation and special review.
Farrokhi S; Shabani M; Aryan Z; Zoghi S; Krolo A; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2018; 46(3):263-275. PubMed ID: 28676232
[TBL] [Abstract][Full Text] [Related]
20. MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.
El Hawary RE; Mauracher AA; Meshaal SS; Eldash A; Abd Elaziz DS; Alkady R; Lotfy S; Opitz L; Galal NM; Boutros JA; Pachlopnik Schmid J; Elmarsafy AM
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):856-863. PubMed ID: 30170160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
